COVID-19 Business Intelligence and Analysis for Clinical Laboratories, Pathology Groups and Hospital Administration

COVID-19 Briefings

Reliable COVID-19 Business Intelligence and analysis for clinical laboratories, pathology groups and Laboratory Diagnostics.

FDA Provides New List of Clinical Laboratory Supplies That Are Being Discontinued by Manufacturers

FDA maze of regulations
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on pinterest
Pinterest
Share on whatsapp
WhatsApp
Share on email
Email
Share on facebook
Share on twitter
Share on linkedin
Share on google
Share on whatsapp
Share on email

FDA’s Discontinuance List includes clinical laboratory testing supplies for the first time

As previously reported by the COVID-19 STAT Intelligence Briefings Service, the US Food and Drug Administration (FDA) has recently begun publishing a list of clinical laboratory supply shortages (See FDA Enhances Medical Device Shortage Resources to Better Reflect the Needs of Clinical Laboratories). On Jan. 22, 2021, the FDA began reporting on another type of supply chain issue that clinical laboratories should be aware of.

The FDA has developed a “Discontinuance List”, which it describes as a “separate, publicly-available, up-to-date list of the devices for which the FDA has been informed by the manufacturer have been discontinued.” This list is kept up to date and includes clinical laboratory supplies.

The FDA’s Discontinuance List has actually been active since mid-August 2020 but did not list any supplies or equipment that pertained to clinical laboratories until recently. Now the list is more useful to laboratorians.

Clinical laboratory leaders wishing to keep track of clinical laboratory supplies will want to keep up to date with supplies that are being discontinued by manufacturers to avoid supply chain shortages and disruptions in testing capabilities. Laboratorians wishing to access this resource can do so here.

COVID-19 TESTING DATA

Helping Your Lab Stay Afloat During Challenging Times

Dear Colleague,

Robert L. MichelIn these challenging times for our colleagues in clinical laboratories, pathology practices and hospital administration, The Dark Intelligence Group (TDIG) — through generous grants from our partners — is bringing you the COVID-19 STAT Intelligence Briefings.

We’ve added analysts, writers and skilled editors to the COVID-19 STAT team to uncover, analyze, and immediately report to you what’s happening with the SARS-CoV-2 pandemic, packaged with the insights you need to deliver quality testing for patient care and keep your lab’s financial ship afloat. As part of our mission, we are also bringing you real-time data from our partners around testing that you will not find anywhere else.

Please let me know how we can better improve this service to fit your needs. If you would like to offer a grant to keep our mission going with this site, please contact me at rmichel@darkreport.com.

Sincerely,

Robert L. Michel
President, Founder
The Dark Intelligence Group